|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,890,000 |
Market
Cap: |
N/A |
Last
Volume: |
2,615,875 |
Avg
Vol: |
1,219,119 |
52
Week Range: |
$7.07 - $7.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wierenga Wendall D |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
8,998 |
|
- |
|
Friedman Cathy |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
7,300 |
|
- |
|
Freund John Gordon |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
8,899 |
|
- |
|
Rieflin William Jl |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
27,670 |
|
- |
|
Fenton Dennis M |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Berns Paul L |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Hilleman Jeryl L |
Director |
|
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2013-05-13 |
4 |
D |
$5.91 |
$5,993 |
D/D |
(1,014) |
98,962 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2013-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,700 |
99,976 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2013-03-12 |
4 |
D |
$7.73 |
$49,998 |
D/D |
(6,468) |
97,276 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2013-03-12 |
4 |
OE |
$2.70 |
$49,999 |
D/D |
18,518 |
103,744 |
|
- |
|
Bosko Gianna M |
SVP, CAO, GC and secretary |
|
2013-03-12 |
4 |
D |
$7.73 |
$50,832 |
D/D |
(6,576) |
60,487 |
|
- |
|
Bosko Gianna M |
SVP, CAO, GC and secretary |
|
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
67,063 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2013-03-12 |
4 |
D |
$7.73 |
$58,099 |
D/D |
(7,516) |
94,278 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
101,794 |
|
- |
|
Savello David R |
SVP, Development |
|
2013-03-12 |
4 |
D |
$7.73 |
$58,099 |
D/D |
(7,516) |
67,693 |
|
- |
|
Savello David R |
SVP, Development |
|
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
75,209 |
|
- |
|
Bates Gregory T |
SVP, Regulatory Affairs & QA |
|
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
19,040 |
|
- |
|
Angotti Vincent |
Executive VP, COO |
|
2013-03-12 |
4 |
D |
$7.73 |
$58,099 |
D/D |
(7,516) |
53,451 |
|
- |
|
Angotti Vincent |
Executive VP, COO |
|
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
60,967 |
|
- |
|
Bates Gregory T |
SVP, Regulatory Affairs & QA |
|
2013-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
281 |
13,415 |
|
- |
|
Savello David R |
SVP, Development |
|
2013-01-28 |
4 |
D |
$8.48 |
$2,714 |
D/D |
(320) |
55,209 |
|
- |
|
Savello David R |
SVP, Development |
|
2013-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
55,529 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2013-01-28 |
4 |
D |
$8.48 |
$3,104 |
D/D |
(366) |
81,794 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2013-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
82,160 |
|
- |
|
663 Records found
|
|
Page 8 of 27 |
|
|